Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the launch of its first fully human Generative AIHCAb (Heavy Chain-Only Antibody) Model powered by its Hu-mAtrIx™ AI platform, built upon the Harbour Mice® platform. This platform establishes a closed-loop process […]

Communications agency recognized as a beacon of progress throughout 14-year client partnership West Cary Group, a leading marketing, advertising, and technology firm headquartered inRichmond, Virginia, has been named the recipient of the 2025 Supplier Impact Award by Capital One. The distinction honors a supplier who has exceeded expectations by serving as a thought partner and

A new platform helps insurance agents reactivate dormant leads, improve ROI, and stay competitive in a rapidly evolving, technology-driven industry. Financialize, a leading insurance marketing and technology company, has officially launched Lead Revival, an AI-powered system that helps insurance agents transform old, inactive leads into verified, show-ready appointments – guaranteed. https://mma.prnewswire.com/media/2804385/Financialize_com_LLC__new_Lead_Revival_platform.jpg New from Financialize: Lead

The appointment reflects Ruder Finn's commitment to strategic growth, innovation,and independence Ruder Finn, one of the world's leading independent communications and integrated marketing firms, today announced the promotion ofRachel SpielmantoChief Strategy & Change Officer, North America. In this newly established role, Spielman will lead initiatives to strengthen the agency's strategic growth, foster deeper integration across

NEW YORK, NY / ACCESS Newswire / October 28, 2025 / If you suffered a loss on your Semler Scientific, Inc. (NASDAQ:SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=174320&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / October 28, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=174319&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Young Americans' views of higher education identify some clear priorities, including the need to instill critical thinking skills and prepare students for careers, according to a new survey of young adults by the Sine Institute of Policy & Politics at American University. The survey of 1,214 young Americans ages 18-34 examined their views on higher

Dr. Rios Brings Personalized Care and Stronger Doctor-Patient Relationships to the Black Hills MDVIP, the nation's leading provider of membership-based healthcare, has launched in South Dakota with its first affiliated practice led by board-certified family physician Gaddiel D. Rios, M.D., in partnership with MED 360 by Monument Health. Dr. Rios, a former U.S. Army doctor

Primary safety endpoint achieved with zero drug-related adverse events; secondary outcomes showed eczema improvement and targeted suppression of Staphylococcus aureus without loss of protective skin microbes Concerto Biosciences®, a clinical-stage biotech company developing microbial products for therapeutics and consumer markets, today announced positive topline results from its first-in-human Phase 1b clinical trial evaluating ENS-002, a

Pumpkin Pet Insurance (pumpkin.care) today released new findings from a national survey of more than 1,200 U.S. pet owners that highlight an important but often overlooked reality: while cat owners cherish their pets as deeply as dog owners do – often referring to them as “children” – they are far less financially prepared to cover